Literature DB >> 1761793

Modulation of epidermal terminal differentiation in patients after long-term topical corticosteroids.

H M Sheu1, C L Tai, K W Kuo, H S Yu, C Y Chai.   

Abstract

The expression of the various markers for terminal epidermal differentiation in atrophic skin of patients after long-term topical corticosteroids (TCS) was studied by electron microscopy, immunofluorescence using antibody to profilaggrin/filaggrin (PF/FG), immunoperoxidase staining using antibody to involucrin, and oil red O stain for neural lipids of the stratum corneum. Thirty-nine patients were subdivided into two groups: (A) 19 patients suffering from rebound phenomenon after stopping TCS and (B) 20 patients without rebound phenomenon. Biopsy specimens were taken before ending the use of TCS in both groups. In group A, both the morphological markers (including the different epidermal strata, keratohyalin granules, lamellar granules, and cornified cell envelopes) and the molecular markers (including involucrin, PF/FG, and neutral lipids) of terminal epidermal differentiation were significantly suppressed. On the other hand, the differentiational markers in the atrophic skin of patients without rebound phenomena were only slightly altered. These results suggest that potent TCS not only has antiproliferative actions but also inhibits the differentiation of epidermis, resulting in structural defects in the epidermis, especially the stratum corneum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1761793     DOI: 10.1111/j.1346-8138.1991.tb03115.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

2.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

3.  11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair.

Authors:  Mika Terao; Hiroyuki Murota; Akihiro Kimura; Arisa Kato; Akiko Ishikawa; Ken Igawa; Eiji Miyoshi; Ichiro Katayama
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

Review 4.  Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.

Authors:  Lisa A Beck; Michael J Cork; Masayuki Amagai; Anna De Benedetto; Kenji Kabashima; Jennifer D Hamilton; Ana B Rossi
Journal:  JID Innov       Date:  2022-04-26

5.  Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.

Authors:  Beom Jun Kim; Noo Ri Lee; Chung Hyeok Lee; Young Bin Lee; Sung Jay Choe; Solam Lee; Hyun Jee Hwang; Eunjung Kim; Gareth G Lavery; Kyong-Oh Shin; Kyungho Park; Eung Ho Choi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

6.  Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction.

Authors:  Mototsugu Fukaya
Journal:  Dermatol Ther (Heidelb)       Date:  2016-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.